Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 25, 2026
UVIX: +13% Over 30 Days on Volatility Repricing, Yet -35% for the Quarter

UVIX: +13% Over 30 Days on Volatility Repricing, Yet -35% for the Quarter

Key Takeaways

  • UVIX advanced roughly 13% over the last 30 days, climbing from about $35.79 to $40.56, driven by a sharp mid-October rise in implied equity-market volatility.
  • Over the last quarter, however, the fund declined about 35%, underscoring how leveraged long-volatility products erode when markets are calm.
  • UVIX is a 2x daily resetting leveraged ETF that seeks twice the daily return of the Long VIX Futures Index (LONGVOL), not a basket of stocks.
  • The fund holds first- and second-month VIX futures plus cash, so its returns hinge on volatility pricing rather than sector fundamentals or company earnings.
  • Two structural forces dominate performance: volatility spikes drive gains, while contango and volatility drag steadily bleed value in quiet conditions.
  • The fund carries a 1.65% management fee and is designed for short-term tactical trading, not long-term buy-and-hold positioning.

Understanding the 2x Long VIX Futures ETF (UVIX)

The 2x Long VIX Futures ETF seeks daily investment results, before fees and expenses, that correspond to twice (200%) the performance of the Long VIX Futures Index (LONGVOL). Maintained by Cboe, LONGVOL expresses the daily performance of a theoretical portfolio of first- and second-month VIX futures contracts that are rolled daily, with its settlement value derived from a 15-minute time-weighted average price (TWAP) during the regular equity session. UVIX, launched by Volatility Shares in March 2022, is a passive, daily-resetting leveraged product that takes a long position in short-term volatility.

Unlike equity ETFs, UVIX does not hold a diversified basket of stocks and has no sector allocation. Its exposure consists of front-month VIX futures contracts, cash, and money-market instruments. The VIX (Cboe Volatility Index) measures the market's 30-day expectation of S&P 500 volatility implied by options pricing. UVIX carries a management fee of 1.65%, and because its leverage resets daily, its returns can diverge significantly from a simple 2x multiple of the VIX over any period longer than a single day. I also checked this using Tickeron’s AI Screener to see how the fund compares to other volatility products.

Recent Price Performance: 30 Days vs. the Quarter

Over the last 30 days, UVIX rose approximately 13%, moving from a closing level near $35.79 to about $40.56. The move was not a smooth trend: the fund spent most of the period grinding near its lows before spiking sharply in mid-October, when daily volume surged and intraday prices jumped from the low $30s toward the low $40s. This pattern is characteristic of long-volatility exposure, which tends to move abruptly rather than gradually.

The quarterly picture is the mirror image. Over the last three months, UVIX fell roughly 35%, declining from about $62.05 to $40.56. In other words, the recent 30-day rebound only partially retraced a longer, deeper drawdown. The contrast between the two timeframes illustrates the fund's core dynamic: steady decay in low-volatility regimes punctuated by sharp, short-lived rallies when fear re-enters the market. From what I see, this kind of pattern shows up clearly when reviewing volatility metrics in Tickeron’s AI tools.

What Drove UVIX Over the Last 30 Days

The 30-day advance was driven almost entirely by a repricing of volatility expectations rather than any change in underlying corporate fundamentals. In mid-October, implied volatility across equity markets climbed, lifting VIX futures and, in turn, the LONGVOL index that UVIX tracks. Because UVIX targets 2x daily exposure, a rise in its benchmark translated into a disproportionately large move in the fund's share price, with elevated trading volume confirming active repositioning.

The VIX futures curve's normal condition is contango (an upward-sloping curve), which forces funds rolling expiring contracts to buy higher-priced longer-dated futures and steadily erodes value. During the mid-October volatility event, a shift in the term structure temporarily reversed that drag, allowing UVIX to capture leveraged gains.

What Drove UVIX Performance Over the Last Quarter

The roughly 35% quarterly decline reflects the cumulative effect of contango and volatility drag. When the VIX futures curve remains in contango and realized volatility stays low, a daily-resetting leveraged fund loses value through the routine roll of futures contracts and through the compounding effect of rebalancing in a trending-down market. This structural erosion occurs even when the broader equity market is modestly positive or range-bound.

The quarterly trend also highlights the asymmetry of the product: the fund's gains are concentrated in brief episodes of market stress, while its losses accumulate steadily the rest of the time. Institutional and tactical traders use vehicles such as UVIX primarily as short-term hedges or speculative tools, and the fund's counterpart, the -1x Short VIX Futures ETF (SVIX), expresses the inverse view.

Using Tickeron’s AI Screener for Volatility Research

Tickeron’s AI Screener has become a regular part of my workflow when looking at products like UVIX. It lets me scan across volatility metrics, price patterns, and performance characteristics in one place, which helps surface ideas that might otherwise get overlooked in manual reviews. I find it especially useful for comparing leveraged ETFs against broader market filters before diving deeper into term-structure details.

UVIX ETF Outlook: What to Watch Next

Going forward, the principal variable for UVIX is the level and shape of the VIX futures curve. Sustained low realized volatility and a steep contango term structure would likely continue to pressure the fund, while any resurgence in equity-market stress, hedging demand, or risk-aversion could trigger sharp, leveraged rallies. Investors should monitor implied volatility levels, the slope of the futures curve, and the pace of institutional hedging activity.

Macroeconomic conditions also matter indirectly. Interest-rate expectations, inflation trends, and economic growth data shape equity risk appetite and, by extension, demand for volatility protection. Because the product is engineered for short holding periods, its risks include contango erosion, volatility drag, and leveraged compounding, all of which are most relevant to investors who hold the fund across multiple sessions rather than using it tactically. I’m watching this closely as volatility conditions evolve.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UVIX

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


UVIX in -4.29% downward trend, declining for three consecutive days on October 21, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UVIX declined for three days, in 373 of 380 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

UVIX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for UVIX entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 59 cases where UVIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on UVIX as a result. In 79 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

UVIX moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +15.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where UVIX advanced for three days, in 139 of 160 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to twice (2x) the performance of the Long VIX Futures Index for a single day. The index measures the daily performance of a portfolio of long positions in first and second month VIX futures contracts. This theoretical portfolio is rolled each day to maintain a consistent time to maturity of the futures contracts. The index is calculated daily at 4:00 p.m. (Eastern time) and at a value calculated from the average price for the futures contracts between 3:45 p.m. (Eastern time) and 4:00 p.m. (Eastern time).
View a ticker or compare two or three
UVIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Volatility Shares LLC2000 PGA Boulevard, Suite 4440
Phone
(866) 261-0273
Web
www.volatilityshares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.